LATEST PRESS RELEASES FROM OCULYZE

Automated Oculyze Better Brewing 2.0 yeast counter: New feature to analyze Brett

Oculyze Better Brewing launches a new feature to analyze Brettanomyces bruxellensis (Brett) concentration in the brewing process. Brett cells are elongated in shape in comparison to Saccharomyces yeast.

Berlin September 9th, 2019: Oculyze GmbH has launched a powerful upgrade for its Better Brewing 2.0 yeast management application: After a period of research and development the app now allows the user to determine Brettanomyces bruxellensis concentration. The characteristic elongated shape of these Brett cells is challenging for automated image recognition because of the inconsistency in shape and size, and due to the overlapping cells and clusters. The Oculyze app provides a solution; a microscopic image is scanned and all elongated cells and particles are detected and then selected after a geometric consistency check. Concentration is measured according to the number of Brett cells while Saccharomyces and other particles are automatically ignored from Brett concentration results.

Brettanomyces is a genus in the class Saccharomycetes and it can produce unique aromas and flavors, which can be described as a barnyard, horse blanket, leather, burnt plastic, wet wool or even sweat. Brett is a yeast, though many brewers assume it is a bacterium. Brett can also be considered as a contaminant and it exists naturally, for example on fruit skins. For some of the brewers Brett is a nightmare, others love the unique flavor it can produce.

Experimenting with Brett has risks. It spreads easily, and without being cautious, Brett can rapidly contaminate all of the beers in a brewery. The microorganism can be transported by airborne particles, equipment or even fruit flies. Proper cleaning and sanitizing procedures will help to isolate it. Some popular beer styles are produced intentionally with Brett including the famous Flanders red and Belgian lambic styles.

Many of the craft brewers, who are using Oculyze BB2.0 yeast counter, have requested an additional feature to the app to accurately count the Brett concentration of the sample. As an agile startup Oculyze is reacting to the requests from users to improve their yeast cell counting and analyzing process. Nevertheless, the new feature is not a general contamination warning.

Kilian Moser, CEO at Oculyze GmbH explains:

“From conversations with breweries, we recognized the need to analyze Brett concentration in yeast samples on top of our existing automatic cell concentration and viability analysis. We launched the feature as a beta version to learn more about the requirements of our customers, since there is no generally accepted standard method for Brett analysis. After launching this version, we would love to get feedback how this innovative solution suits their analyzing needs.”

******ENDS****

Oculyze to develop innovative application for vintners

March 2019: Oculyze today announced that it had secured a grant from the German Federation of Industrial Research Associations (AiF) to adapt its innovative yeast cell counting technology towards the needs of winemakers enabling them to accurately and instantly analyze yeast concentrations before and during the wine fermentation process. The project, jointly managed between Oculyze and the Weincampus Neustadt, is currently in the development phase and is expected to roll out through pilot customer testing during the second half of 2019.

Announcing the grant, Kilian Moser, co-founder and Chief Executive Officer of Oculyze said:

“Following on from our business successes in 2018, I am pleased to accept this grant from the AiF, which helps reinforce our position as the world’s premier platform and go-to-brand for automated image analysis through the development of yet another innovation, this time geared towards vintners.

Whilst 2018 was one of the hottest and driest spring and summers on record in Germany, it proved to be both historic and fortunate for local winemakers with record harvests and an increase in wine production as compared to previous years. At Oculyze, we believe that the timing for the roll out of our latest innovation aptly titled Oculyze Fermentation Wine (FW), couldn’t be more opportune as our technology will help winemakers achieve the maximum potential out of their grapes in the coming season.

The Oculyze FW will be developed jointly with the Weincampus Neustadt, our partner in this venture and will come equipped with several new technological advancements. I take this opportunity to thank the AiF for their faith in our capabilities and their continued commitment and support towards promoting applied research and development overall in Germany, benefiting several small and medium-sized businesses.”

Speaking about the partnership Professor Dr. Maren Scharfenberger-Schmeer at Weincampus said:

“We are very pleased to have received this Grant jointly with Oculyze from the AiF helping bring the Oculyze FW to success. As professor for microbiology I always teach my students the importance of following the microbial activities during wine fermentation. However, most of the winemakers currently do not monitor the microorganisms due to time and cost reasons. Therefore I think it is a great opportunity to analyze the yeast dynamics by Oculyze FW during fermentation leading to higher process control and improved wine quality. Here at the Weincampus we have several years of experience in wine fermentation and strong connection with local winemakers. Therefore the results of this project, lead by microbiologist Dr. Kathrin Diesler, can be directly transferred to the wine cellar.”

Commenting on the new development, Dr. Ulrich Tillich, co-founder and Chief Technology Officer of Oculyze said:

“The German wine market is very liberal and produces close to a billion liters of wine a year, making it the tenth largest wine producing country in the world. A lot of emphasis is therefore placed on quality. The careful analysis of yeast before and during the fermentation process is critical to the quality and consistency of the wine making process enabling winemakers to detect any problems earlier.

This is where we can make a big difference and ensure consistency in the final deliverable through the use of our innovative technology. I am excited to begin working on this project and look forward to yet another successful roll out from Oculyze.”

The Weincampus Neustadt is a joint academic department at the University of Applied Sciences in Ludwigshafen am Rhein, Bingen and Kaiserslautern. The academic department offers the dual-study bachelor degree program “Viticulture and Oenology” and the part-time master’s degree program “MBA Wine, Sustainability and Sales”. It also conducts research in the fields of viticulture and oenology.

******ENDS****

Oculyze receives investment boost

March 2019: Oculyze today announced that it had secured a seven figure investment from Constantia New Business (CNB) GmbH headquartered in Vienna, Austria. CNB is a venture capital investor working with high-tech startups inspired by the idea of creating impactful companies and joins Oculyze’s existing investor since 2017 BFB Brandenburg Kapital GmbH. The funds will be utilized to support Oculyze’s plans to grow the current business exponentially, specifically supporting late-stage research and development of additional products in the Oculyze portfolio and further market expansion both within Germany and across the world.

Commenting on the latest development, Kilian Moser, co-founder and Chief Executive Officer of Oculyze said:

“As we embark on a new year, I am delighted to announce that we have secured further funding through a new partnership with Austrian based CNB. This latest funding comes at a very exciting time for Oculyze as we seek to consolidate and sustain our position as the world’s premier platform for mobile image analysis.

During 2018, we strengthened our core team through the hiring of senior professionals, bringing in a wealth of experience and expertise crucial to the future growth of Oculyze. In addition, and after developing and enhancing our technology, we rolled out our flagship product – the Oculyze Better Brewing (BB) 2.0 as well as signed on a global distribution partner to extend our product to an even bigger audience across the world. During the last quarter of 2018, we launched our online store, automating and streamlining the entire purchase-to-fulfillment process within a safe and secure environment. All these developments have resulted in a steady increase in sales and a customer reach across 26 countries.

We take this opportunity to thank the team at CNB for their invaluable support and will continue to focus on creating greater value for all our stakeholders.”

Speaking at the signing, Sabine Fleischmann, Senior Investment Manager at CNB said:

“We are thrilled to collaborate with an innovative German firm like Oculyze as it looks to delivering on its vision to provide automated image analysis to anyone anywhere. As an independent Austrian venture capital investor, we are always on the look-out for innovative young companies across Europe that are backed by an experienced and professional team who fit our investment and business model and seek a partner to support them both financially and as a hands-on partner during the next growth stage. We are glad to extend our full support to them and look forward to a fruitful partnership”

******ENDS****

Oculyze & BIOTECON Diagnostics sign strategic partnership

 

December 2018: Oculyze and BIOTECON Diagnostics recently announced the signing of a strategic partnership. The agreement signed at the corporate offices of BIOTECON Diagnostics in Potsdam, appoints the Company as the exclusive global distributor of Oculyze’s latest technological innovation the Oculyze Better Brewing (BB) 2.0. The Oculyze BB 2.0, a quality German made hardware/software combination, enables breweries to determine viability and concentration of their yeast in less than a minute. It is compact, weighing under 200 g and can easily fit within the palm of a brewer’s hand. The technology comes equipped with a high quality optical scope that is comparable to a high end laboratory microscope and is compatible with most android mobile phones and tablets.

Signing the agreement, Kilian Moser, co-founder and Chief Executive Officer of Oculyze said:

“I am delighted to announce this strategic partnership with BIOTECON Diagnostics as we look to rapidly build and consolidate the Oculyze BB 2.0 market share and brand value across the world. As a relatively young and innovative biotech firm, we believe in focusing on our core strengths to continuously create and roll out key technological solutions that are smart, easy to use and cost efficient.

By entrusting BIOTECON Diagnostics to manage the global distribution of our flagship product, we are confident of capitalizing on their strengths towards offering the Oculyze BB 2.0 to an even wider audience. BIOTECON Diagnostics brings a wealth of experience within the area of sales and distribution by cooperating with leading international manufacturers, and we look forward to the beginning of a mutually beneficial and successful partnership.”

Speaking on behalf of BIOTECON Diagnostics, Alois Schneiderbauer, Chief Business Officer of BIOTECON Diagnostics said:

“BIOTECON Diagnostics is proud of the long-standing relationships that have been built up over the years with various partners, also in the brewing sector, and we continue to focus on expanding our product portfolio. We are, therefore, pleased to have the confidence to add the Oculyze BB 2.0 to our global portfolio as we also believe in the technology and advantage of the product and have many common interests with Oculyze. We look forward to further developing this relationship and contributing to the establishment and market presence of the Oculyze BB 2.0”.

******ENDS****

Oculyze launches Better Brewing (BB) 2.0 at Braubeviale 2018

November 2018: Oculyze today announced the launch of its latest technological innovation, the Oculyze Better Brewing (BB) 2.0, the lightest automated cell counter in the world today. The Oculyze BB 2.0 was unveiled at a press conference held at the BrauBeviale trade fair, the world’s biggest capital goods fair for the beverage industry and specifically one of the most important European trade fairs for the production and marketing of beer and soft drinks.

The Oculyze BB 2.0, a hardware software combination proudly made in Germany, enables breweries to determine viability and concentration of their yeast in less than a minute. It is compact enough, weighing in at just under 200g and can easily fit within the palm of a brewers hand. The technology comes equipped with a high quality optical scope that is comparable to a high end laboratory microscope, boasting a 400 X magnification. A forward facing focusing wheel can be easily adjusted to focus the lens, whilst the head of the cell counter also featuring a time-sensitive LED, ensuring that the device is never left to waste excess energy. Another major change to the technology is that the Oculyze BB 2.0 is now compatible with most android mobile phones and tablets

Announcing the launch, Kilian Moser, co-founder and Chief Executive Officer of Oculyze said:

“In line with our vision to provide automated image analysis for anyone anywhere, I am pleased to launch yet another innovation that raises the bar once again in simple and economic on-site analysis

The Oculyze BB 2.0 is by far the lightest automatic cell counter in the world today and revolutionizes the way brewers count their yeast. It is not only more accurate but significantly faster and cheaper than competing products and drastically reduces repitching costs by thousands of Euros per year, whilst ensuring the same consistent taste and quality in beer. Through our innovation, brewers can now connect our device to most android mobile phones or tablets via a USB cable, take pictures and upload them to our safe and secure cloud server and receive their analysis in seconds. Additionally, our app integrates the latest technology and also provides an environment for automatic documentation and data backup.
With our previous model, we strove to simplify the process of yeast analysis for brewers, and we achieved this by making the device accessible to all levels of experience. The Oculyze BB 2.0 continues in the same vain, with a simple plug and play functionality that can be easily navigated by the most novice of brewers.

The team at Oculyze are currently looking at several new innovations that are in various stages of development, across vast fields that range from agriculture to a point of care diagnostic tool and through the launch of Oculyze BB 2.0 we reinforce our position as the world’s premier platform and go-to-brand for automated image analysis.”

Oculyze is currently exhibiting alongside various other young companies from Germany that develop innovative products and processes for the beverage industry as part of the exclusive line up of exhibitors making up the Innovation made in Germany Pavilion.

******ENDS****

Oculyze receives Phase 1 grant approval from European Union Horizon 2020 Program

August 2018: Oculyze today announced that it had recently been awarded a Phase 1 grant of €50,000 by the prestigious European Union Horizon 2020 Research and Innovation Program. In line with the requirements for obtaining the initial phase approval, Oculyze delivered a strategic presentation on the feasibility and commercial potential of its proprietary mobile microscopy solution for veterinarians and dairy farmers, enabling them to easily diagnose subclinical endometritis amongst dairy cattle with a high degree of accuracy on the farm itself within seconds, without having to lug around huge microscopes. Once treated, the affected cattle quickly recover and regain normal output levels, improving herd well-being and increasing farmer revenue.

Commenting on the recent development, Kilian Moser, Co-founder and Chief Executive Officer of Oculyze said:

“It is truly an honor to qualify past phase 1 and to be counted amongst the chosen few, given the high level of competitive ideas and proposals submitted by our like-minded contemporaries from across the EU. This approval, reinforces our collective efforts at Oculyze and strengthens our commitment towards delivering on our vision to provide automated image analysis to anyone anywhere.

Our latest mobile microscopy innovation is based on the most sophisticated image recognition techniques developed inhouse and provides automatic data upload, storage, as well as results management within our easily accessible cloud-based system.

We are now gearing up towards delivering on our objectives to include prototyping, pilot lines and testing for performance and verification of data amongst others as part of receiving the next level of funding. On behalf of our co-founders, I take this opportunity to thank the EU and Horizon 2020 for their faith in our service and product and commit to continue the work on developing further innovative products.”


The Innovation Union is one of seven Europe 2020 strategy flagship initiatives, aimed at securing Europe’s global competitiveness for smart, sustainable and inclusive growth. One of the key goals of the Innovation Union is to transform Europe unto a world-class science performer with Horizon 2020 leading from the front as its financial instrument geared solely towards implementation. Horizon 2020 is the biggest EU Research and Innovation program, with nearly €80 billion in funding available over 7 years (2014 to 2020). The initiative was designed to fund excellent research and to deliver on innovation- taking research outcomes to the market in order to enhance the impacts of research investment.

Horizon 2020 brings together all existing EU research and innovation funding combining the funding previously separately available from the Framework Program for research and technological development (FP), the innovation-related activities of the Competitiveness and Innovation Framework Program (CIP) and the European Institute of Innovation and Technology (EIT).

*****************ENDS*****************

OCULYZE win the Innovation Prize 2018

October, 2018



Intervitis Interfructa Hortitechnica


Oculyze wins gold medal prize for their hand-held microscope

Oculyze win a gold medal prize courtesy of the Intervitis Interfructa Hortitechnica. They will be showcasing their technology at the international technology trade fair and celebrating their accomplishment.

Continue reading →


OCULYZE featured in Märkische Allgemeine

October, 2018



Märkische Allgemeine

Oculyze featured in Märkische Allgemeine, the largest regional newspaper in Germany

Continue reading →


OCULYZE to showcase latest innovation at BrauBeviale 2018

October, 2018



Exist

Oculyze gears up to showcase its latest technological innovation at BrauBeviale

Oculyze, a spinoff from the Technical University (TH) Wildau and the world’s premier platform for mobile image analysis, today announced that it would be participating at the forthcoming BrauBeviale trade fair to be held from the 13th to the 15th of November 2018 in Nuremberg. BrauBeviale is the world’s biggest capital goods fair for the beverage industry and specifically one of the most important European trade fairs for the production and marketing of beer and soft drinks. Oculyze will be exhibiting alongside various other young companies from Germany that develop innovative products and processes for the beverage industry as part of the exclusive line up of exhibitors making up the Innovation made in Germany Pavilion.

Continue reading →


Create locally, think globally

September, 2018



Exist

We currently have paying customers in 17 different countries

Continue reading →


The smart smartphone-microscope

September, 2018



Brauwelt International

The smart smartphone-microscope featured in ILB:

Continue reading →


Automatic cell counting in the palm of your hand

August, 2018



Brauwelt International

Automatic cell counting in the palm of your hand

“Counting yeast cells is one of the more tedious and repetitive tasks in the beer industry. It requires either a skilled professional to perform a manual count with a microscope and a hemocytometer or an expensive piece of equipment – or both. Challenges exist in this process, even for professionals performing a good cell count. Did I count that cell? Is that daughter cell 50 per cent the size of the mother cell or less? Should I count that blueish cell as alive or dead…”

Continue reading →


OCULYZE receives phase 1 grant approval from the
European Union

August, 2018

European Union Grant

Oculyze receives Phase 1 grant approval from European Union Horizon 2020 Program

Oculyze, a spinoff from the Technical University (TH) Wildau and the world’s premier platform for mobile image analysis, today announced that it had recently been awarded a Phase 1 grant of €50,000 by the prestigious European Union Horizon 2020 Research and Innovation Program. In line with the requirements for obtaining the initial phase approval, Oculyze delivered a strategic presentation on the feasibility and commercial potential of its proprietary mobile microscopy solution for veterinarians and dairy farmers, enabling them to easily diagnose subclinical endometritis amongst dairy cattle with a high degree of accuracy on the farm itself within seconds, without having to lug around huge microscopes. Once treated, the affected cattle quickly recover and regain normal output levels, improving herd well-being and increasing farmer revenue.

Commenting on the recent development, Kilian Moser, Co-founder and Chief Executive Officer of Oculyze said:

“It is truly an honor to qualify past phase 1 and to be counted amongst the chosen few, given the high level of competitive ideas and proposals submitted by our like-minded contemporaries from across the EU. This approval, reinforces our collective efforts at Oculyze and strengthens our commitment towards delivering on our vision to provide automated image analysis to anyone anywhere.

Our latest mobile microscopy innovation is based on the most sophisticated image recognition techniques developed inhouse and provides automatic data upload, storage, as well as results management within our easily accessible cloud-based system.

We are now gearing up towards delivering on our objectives to include prototyping, pilot lines and testing for performance and verification of data amongst others as part of receiving the next level of funding. On behalf of our co-founders, I take this opportunity to thank the EU and Horizon 2020 for their faith in our service and product and commit to continue the work on developing further innovative products.”

The Innovation Union is one of seven Europe 2020 strategy flagship initiatives, aimed at securing Europe’s global competitiveness for smart, sustainable and inclusive growth. One of the key goals of the Innovation Union is to transform Europe unto a world-class science performer with Horizon 2020 leading from the front as its financial instrument geared solely towards implementation. Horizon 2020 is the biggest EU Research and Innovation program, with nearly €80 billion in funding available over 7 years (2014 to 2020). The initiative was designed to fund excellent research and to deliver on innovation- taking research outcomes to the market in order to enhance the impacts of research investment.

Horizon 2020 brings together all existing EU research and innovation funding combining the funding previously separately available from the Framework Program for research and technological development (FP), the innovation-related activities of the Competitiveness and Innovation Framework Program (CIP) and the European Institute of Innovation and Technology (EIT).

For further information, please contact:

Gordon Andrade; Head, Marketing and Communications
Oculyze GmbH
E-mail: gordon@oculyze.de
Cell: +49 151 7005 7001


OCULYZE selected to join German Accelerator Tech Program

April, 2018

Oculyze accepted into the German Accelerator Tech program in Silicon Valley

Wildau, April 27th 2018 – Oculyze GmbH, a cloud-based image recognition and mobile microscope provider, has been selected to join the German Accelerator Tech program in Silicon Valley. The main focus of this program is on providing German tech startups with the support to scale in the US market. In addition to receiving hands-on mentoring and free coworking space in the Valley, the Oculyze founding team members will have immediate access to a top-notch network of partners and potential investors. This program is supported by the German government and will allow Oculyze the opportunity to further develop the mobile image recognition solution for a global marketplace.

Ulrich Tillich, CTO at Oculyze states, “Image recognition is the core of our business, it’s where we thrive. The capabilities of our software open up the potential for our system to be used across many industries – a number of applications are currently in various stages of development. We believe that this is what made Oculyze so attractive to the judges and quite possibly the main reason we were selected to join the program.”

After several rounds of discussions and meetings with various potential partners in Germany, the team is finalizing the next steps toward entering the markets for the following applications: subclinical endometritis detection in dairy cows, malaria detection in rural areas, the monitoring of wastewater contaminants and non-destructive surface testing. Tillich remarks, “As they announced the winners at the Celebrating Innovation event, I was over-the-moon excited. I knew that being part of this program will help us gain access to these markets in the United States with a much stronger base of support.”

Growing Globally and Growing Fast

CEO, Kilian Moser explains, “We already have a number of customers for our first application in the craft beer market in the US but it’s still small scale – our participation in the German Accelerator in the Valley will pave the way for our search for a smart money investor who will help us grow globally and fast.” Oculyze GmbH has a worldwide customer base across 15 countries, including countries in North America, Australia, Europe and Asia. “The US market is a huge opportunity for us, not just for our Better Brewing application but for the number of other applications currently in our pipeline. So for us, this program is a natural next step” Moser adds.